Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*
Jean‐Louis Vincent(Université Libre de Bruxelles), Gordon R. Bernard(Vanderbilt University Medical Center), Bruce R. Basson(Universitat Autònoma de Barcelona), André C. Kalil(Nebraska Medical Center), Hassan H. Jamal(Middle Technical University), Derek C. Angus(MACOM (United States)), Gerald D. Johnson(Universitat Autònoma de Barcelona), Antonio Artigas(University of Milan)
Cited by 302
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k